SYNTEX CARDENE (NICARDIPINE) LABELING SHOULD ADDRESS LARGE PEAK/TROUGH DIFFERENCES, COMMITTEE SAYS; CARDENE IS APPROVABLE FOR HYPERTENSION -- FDA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet